HCPCS Level II code V5040 designates a monaural, body-worn bone conduction hearing aid. This device class is used to provide auditory rehabilitation for patients with conductive or mixed hearing loss who are candidates for bone conduction amplification. Nationally, billing for bone conduction hearing aids has implications for durable medical equipment coverage, provider billing practices, and access to audiology services.

Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coverage and billing considerations across major national payers, typical sites of service where the device is fitted and dispensed, and common clinical contexts for use. The publication summarizes benchmark reimbursement approaches, common billing modifiers and documentation themes, and policy updates that affect device coverage.

This report is intended to inform billing professionals, audiologists, and policy analysts about the clinical purpose of V5040, expected service settings, and payer landscape. Data not available in the input where specific payer rates, associated ICD-10 diagnoses, related codes, taxonomies, and service-line details would normally appear.